WuXi pushes investors into frenzy with IPO
Investors went crazy for WuXi Biologics’ HK$3.9bn ($500.4m) Hong Kong IPO, driving pricing to the top of expectations as hundreds of global accounts poured in.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: